Wednesday, January 31, 2018

SkylineDx Inks Joint Development Agreement with Mayo Clinic to Develop Diagnostic Tests for Melanoma

ROTTERDAM, Netherlands, Jan. 31, 2018 /PRNewswire/ -- SkylineDx today announced a strategic collaboration with Mayo Clinic to develop novel diagnostic tests which will improve clinical decision making for melanoma patients. For SkylineDx, the collaboration with the renowned Mayo Clinic is...




from PR Newswire: //http://ift.tt/2noe5tD

No comments:

Post a Comment